Regarding the use of Granulocyte colony-stimulating factors(G-CSF), primary G-CSF prophylaxis (G-CSF administration in the first cycle of chemotherapy before the onset of neutropenia) was not performed in both groups. This evidence concerns the gene CSF3 and Decreased total neutrophil count.